| For: | Bu XM, Zhao CH, Zhang N, Gao F, Lin S, Dai XW. Hypermethylation and aberrant expression of secreted fizzled-related protein genes in pancreatic cancer. World J Gastroenterol 2008; 14(21): 3421-3424 [PMID: 18528941 DOI: 10.3748/wjg.14.3421] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i21/3421.htm |
| Number | Citing Articles |
| 1 |
Merja Bläuer, Matias Laaninen, Juhani Sand, Johanna Laukkarinen. Wnt/β-catenin signalling plays diverse functions during the process of fibrotic remodelling in the exocrine pancreas. Pancreatology 2019; 19(2) doi: 10.1016/j.pan.2019.02.003
|
| 2 |
YOUTU WU, CHUNHUI LIU, SHENGYUAN YU, HUA GAO, ZHENYE LI, CHUZHONG LI, YAZHUO ZHANG. Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas. Oncology Reports 2016; 35(5) doi: 10.3892/or.2016.4650
|
| 3 |
Ye Zhang, Bin Yang, Zhi Du, Ying-Tang Gao, Yi-Jun Wang, Xiang Jing, Tong Bai. Identification and validation of specific methylation profile in bile for differential diagnosis of malignant biliary stricture. Clinical Biochemistry 2010; 43(16-17) doi: 10.1016/j.clinbiochem.2010.08.013
|
| 4 |
Jianhong An, Tingting Jiang, Ling Qi, Keping Xie. Acinar cells and the development of pancreatic fibrosis. Cytokine & Growth Factor Reviews 2023; doi: 10.1016/j.cytogfr.2023.05.003
|
| 5 |
Iris Gehrke, Rajesh Kumar Gandhirajan, Karl-Anton Kreuzer. Targeting the WNT/β-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options. European Journal of Cancer 2009; 45(16) doi: 10.1016/j.ejca.2009.08.003
|
| 6 |
Benjamin E. Stubbe, Poul H. Madsen, Anders C. Larsen, Henrik B. Krarup, Inge S. Pedersen, Carsten P. Hansen, Julia S. Johansen, Stine D. Henriksen, Ole Thorlacius-Ussing. Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma. Pancreatology 2023; 23(5) doi: 10.1016/j.pan.2023.05.003
|
| 7 |
Jana Reins, Maximilian Mossner, Martin Neumann, Uwe Platzbecker, Christiane Schumann, Eckhard Thiel, Wolf-Karsten Hofmann. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS. Leukemia Research 2010; 34(12) doi: 10.1016/j.leukres.2010.04.013
|
| 8 |
Chenghai Zhao, Haiying Ma, Xianmin Bu, Wei Wang, Ning Zhang. SFRP5 inhibits gastric epithelial cell migration induced by macrophage-derived Wnt5a. Carcinogenesis 2013; 34(1) doi: 10.1093/carcin/bgs309
|
| 9 |
Sebastian Pohl, Ross Scott, Frank Arfuso, Vanathi Perumal, Arun Dharmarajan. Secreted frizzled-related protein 4 and its implications in cancer and apoptosis. Tumor Biology 2015; 36(1) doi: 10.1007/s13277-014-2956-z
|
| 10 |
D. Wehrum, A. Hartmann, R. Stoehr, R. Gruetzmann, C. Pilarsky, H.D. Saeger. Chirurgisches Forum und DGAV Forum 2010. Deutsche Gesellschaft für Chirurgie 2010; 39 doi: 10.1007/978-3-642-12192-0_20
|
| 11 |
. 2022; doi: 10.70675/d4b968d2z957cz4c8ez813fz6ff9e5102ade
|
| 12 |
Stefan David, Stephen J. Meltzer. Pre-Invasive Disease: Pathogenesis and Clinical Management. 2011; doi: 10.1007/978-1-4419-6694-0_4
|
| 13 |
Masahiro Gotoh, Eri Arai, Saori Wakai-Ushijima, Nobuyoshi Hiraoka, Tomoo Kosuge, Fumie Hosoda, Tatsuhiro Shibata, Tadashi Kondo, Sana Yokoi, Issei Imoto, Johji Inazawa, Yae Kanai, Alain Filloux. Diagnosis and Prognostication of Ductal Adenocarcinomas of the Pancreas Based on Genome‐Wide DNA Methylation Profiling by Bacterial Artificial Chromosome Array‐Based Methylated CpG Island Amplification. BioMed Research International 2011; 2011(1) doi: 10.1155/2011/780836
|
| 14 |
Youtu Wu, Jiwei Bai, Zhenye Li, Fei Wang, Lei Cao, Chunhui Liu, Shengyuan Yu, Guoqiang Yu, Yazhuo Zhang. Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma. Pituitary 2015; 18(3) doi: 10.1007/s11102-014-0579-4
|
| 15 |
Hina Sultana, Abhishikt David Solomon, Atif Khurshid Wani, Surendra K. Shukla. Epigenetic dysregulation in pancreatic cancer: emerging biomarkers and clinical applications. Frontiers in Epigenetics and Epigenomics 2025; 3 doi: 10.3389/freae.2025.1723159
|
| 16 |
Miao Cheng, Zhe Zhu, Shuyuan Ye, Junfeng Chen, Xunjun Dong, Guosheng Gao. Clinical Value of Plasma Secreted Frizzled-Related Protein 4 in the Chronic Hepatitis B Virus Infection: A Cross-sectional Study. Hepatitis Monthly 2021; 21(7) doi: 10.5812/hepatmon.116525
|
| 17 |
Salvatore Chirumbolo, Geir Bjørklund. Can Wnt5a and Wnt non-canonical pathways really mediate adipocyte de-differentiation in a tumour microenvironment?. European Journal of Cancer 2016; 64 doi: 10.1016/j.ejca.2016.05.026
|
| 18 |
Sohei Kitazawa, Ryuma Haraguchi, Riko Kitazawa. Morphology-oriented epigenetic research. Histochemistry and Cell Biology 2018; 150(1) doi: 10.1007/s00418-018-1675-8
|
| 19 |
Maximilian Hauschulz, Sophia Villwock, Jennifer Kosinski, Florian Steib, Lara Rosaline Heij, Jan Bednarsch, Ruth Knüchel-Clarke, Edgar Dahl. Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer. Cancers 2023; 15(3) doi: 10.3390/cancers15030683
|
| 20 |
Priscilla Brebi, Rene Hoffstetter, Alejandra Andana, Carmen G. Ili, Kathleen Saavedra, Tamara Viscarra, Javier Retamal, Raul Sanchez, Juan C. Roa. Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I. Biomarkers 2014; 19(3) doi: 10.3109/1354750X.2013.867535
|
| 21 |
Lingqun Yu, Fei Fang, Minpu Zhang, Ye Li, Mingzhen Li, Changgang Sun, Jing Zhuang, Cun Liu. The Janus Face of sFRP4 in Cancer: From Mechanistic Complexity to Therapeutic Potential. International Journal of Molecular Sciences 2026; 27(13) doi: 10.3390/ijms27135693
|
| 22 |
Jun Yu, Yang Xie, Mengying Li, Fenfang Zhou, Zhenyang Zhong, Yuting Liu, Feng Wang, Jian Qi. Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta‑analysis. Oncology Letters 2019; doi: 10.3892/ol.2019.10709
|
| 23 |
Benjamin Stubbe, Malene P. Stoico, Simone K. Terp, Poul H. Madsen, Søren Lundbye-Christensen, Carsten P. Hansen, Laurids Ø. Poulsen, Louise S. Rasmussen, Mette N. Yilmaz, Lars H. Jensen, Torben F. Hansen, Per Pfeiffer, Anders C. Larsen, Henrik B. Krarup, Inge S. Pedersen, Jane P. Hasselby, Astrid Z. Johansen, Inna M. Chen, Julia S. Johansen, Ole Thorlacius-Ussing, Stine D. Henriksen. Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1568386
|
| 24 |
Christian Bernreuther, Ferdous Daghigh, Katharina Möller, Claudia Hube-Magg, Maximilian Lennartz, Florian Lutz, Sebastian Dwertmann Rico, Christoph Fraune, David Dum, Andreas M. Luebke, Till Eichenauer, Christina Möller-Koop, Thorsten Schlomm, Corinna Wittmer, Hartwig Huland, Hans Heinzer, Markus Graefen, Alexander Haese, Eike Burandt, Maria Christina Tsourlakis, Till S. Clauditz, Doris Höflmayer, Jakob R. Izbicki, Ronald Simon, Guido Sauter, Sarah Minner, Stefan Steurer, Jan Meiners. Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions. Pathology & Oncology Research 2020; 26(4) doi: 10.1007/s12253-020-00861-9
|
| 25 |
Jian Zhu, Yuyan Wang, Jianchun Duan, Hua Bai, Zhijie Wang, Lai Wei, Jun Zhao, Minglei Zhuo, Shuhang Wang, Lu Yang, Tongtong An, Meina Wu, Jie Wang. DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research 2012; 31(1) doi: 10.1186/1756-9966-31-80
|
| 26 |
H Listing, W A Mardin, S Wohlfromm, S T Mees, J Haier. MiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancer. British Journal of Cancer 2015; 112(1) doi: 10.1038/bjc.2014.587
|
| 27 |
Rajesh Singh, James W. Lillard, Shailesh Singh. Epigenetic Advancements in Cancer. 2016; doi: 10.1007/978-3-319-24951-3_2
|
| 28 |
Alexandra Filipovich, Iris Gehrke, Simon J. Poll-Wolbeck, Karl-Anton Kreuzer. Physiological inhibitors of Wnt signaling. European Journal of Haematology 2011; 86(6) doi: 10.1111/j.1600-0609.2011.01592.x
|
| 29 |
Xu Han, Hexige Saiyin, Junjie Zhao, Yuan Fang, Yefei Rong, Chenye Shi, Wenhui Lou, Tiantao Kuang. Overexpression of miR-135b-5p promotes unfavorable clinical characteristics and poor prognosis via the repression of SFRP4 in pancreatic cancer. Oncotarget 2017; 8(37) doi: 10.18632/oncotarget.19150
|
| 30 |
Shilong Han, Chuanwu Cao, Tao Tang, Chenhui Lu, Jichong Xu, Shi Wang, Lei Xue, Xiaoping Zhang, Maoquan Li. ROBO3 promotes growth and metastasis of pancreatic carcinoma. Cancer Letters 2015; 366(1) doi: 10.1016/j.canlet.2015.06.004
|
| 31 |
Rabab M. Aly, Mona M. Taalab, Eman M. Abdsalam. Prognostic Significance of Secreted Frizzled-Related Protein 2 Expression in Cytogenetically Normal Primary Acute Myeloid Leukemia. The American Journal of the Medical Sciences 2015; 350(5) doi: 10.1097/MAJ.0000000000000567
|
| 32 |
Jongbum Kim, Sangsoo Kim. In silicoIdentification ofSFRP1as a Hypermethylated Gene in Colorectal Cancers. Genomics & Informatics 2014; 12(4) doi: 10.5808/GI.2014.12.4.171
|
| 33 |
Rohit Surana, Sakshi Sikka, Wanpei Cai, Eun Myoung Shin, Sudha R. Warrier, Hong Jie Gabriel Tan, Frank Arfuso, Simon A. Fox, Arun M. Dharmarajan, Alan Prem Kumar. Secreted frizzled related proteins: Implications in cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1845(1) doi: 10.1016/j.bbcan.2013.11.004
|
| 34 |
Karlijn van Loon, Elisabeth J. M. Huijbers, Arjan W. Griffioen. Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis. Cancer and Metastasis Reviews 2021; 40(1) doi: 10.1007/s10555-020-09941-3
|
| 35 |
Anja Kafka, Nives Pećina-Šlaus, Denis Drmić, Anja Bukovac, Niko Njirić, Kamelija Žarković, Antonia Jakovčević. SFRP4 protein expression is reduced in high grade astrocytomas which is not caused by the methylation of its promoter. Frontiers in Molecular Neuroscience 2024; 17 doi: 10.3389/fnmol.2024.1398872
|
| 36 |
Stine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, Martin Berg Johansen, Inge Søkilde Pedersen, Henrik Krarup, Ole Thorlacius-Ussing. Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma. Oncotarget 2017; 8(55) doi: 10.18632/oncotarget.21397
|